These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30882399)

  • 1. Ras inhibition by zoledronic acid effectively sensitizes cervical cancer to chemotherapy.
    Xu J; Pan Q; Ju W
    Anticancer Drugs; 2019 Sep; 30(8):821-827. PubMed ID: 30882399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin enhances chemotherapy in cervical cancer via inhibition of multiple prenylation-dependent GTPases-regulated pathways.
    Pan Q; Xu J; Ma L
    Fundam Clin Pharmacol; 2020 Feb; 34(1):32-40. PubMed ID: 31058344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bisphosphonate zoledronic acid effectively targets lung cancer cells by inhibition of protein prenylation.
    Xie F; Li P; Gong J; Zhang J; Ma J
    Biochem Biophys Res Commun; 2015 Nov; 467(4):664-9. PubMed ID: 26498526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway.
    Pan Q; Liu R; Banu H; Ma L; Li H
    Biomed Pharmacother; 2018 Mar; 99():169-175. PubMed ID: 29331763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
    Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt/β-catenin signaling.
    Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
    Biochem Biophys Res Commun; 2015 Nov; 467(1):14-20. PubMed ID: 26427870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin augments temozolomide's efficacy in glioblastoma via prenylation-dependent inhibition of Ras signaling.
    Peng P; Wei W; Long C; Li J
    Biochem Biophys Res Commun; 2017 Jul; 489(3):293-298. PubMed ID: 28554840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
    Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
    Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.
    Kenessey I; Kói K; Horváth O; Cserepes M; Molnár D; Izsák V; Dobos J; Hegedűs B; Tóvári J; Tímár J
    Oncotarget; 2016 Nov; 7(48):79503-79514. PubMed ID: 27780929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway.
    Liu F; Tong D; Li H; Liu M; Li J; Wang Z; Cheng X
    Oncotarget; 2016 Feb; 7(8):8896-907. PubMed ID: 26758421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenylation-dependent Ras inhibition by pamidronate inhibits pediatric acute myeloid leukemia stem and differentiated cell growth and survival.
    Wang C; Liu X; He R; Li J; Pan R
    Biochem Biophys Res Commun; 2019 Sep; 517(3):439-444. PubMed ID: 31376932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines.
    Miyamoto Y; Nakagawa S; Wada-Hiraike O; Seiki T; Tanikawa M; Hiraike H; Sone K; Nagasaka K; Oda K; Kawana K; Nakagawa K; Fujii T; Yano T; Kozuma S; Taketani Y
    Oncol Rep; 2013 Jan; 29(1):51-7. PubMed ID: 23064281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models.
    Schrauwen S; Depreeuw J; Coenegrachts L; Hermans E; Lambrechts D; Amant F
    Gynecol Oncol; 2015 Jul; 138(1):165-73. PubMed ID: 25933683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cells.
    Garay T; Kenessey I; Molnár E; Juhász É; Réti A; László V; Rózsás A; Dobos J; Döme B; Berger W; Klepetko W; Tóvári J; Tímár J; Hegedűs B
    PLoS One; 2015; 10(2):e0117021. PubMed ID: 25646931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next Generation Lipophilic Bisphosphonate Shows Antitumor Effect in Colorectal Cancer In Vitro and In Vivo.
    Baranyi M; Rittler D; Molnár E; Shirasawa S; Jalsovszky I; Varga IK; Hegedűs L; Németh A; Dank M; Aigner C; Tóvári J; Tímár J; Hegedűs B; Garay T
    Pathol Oncol Res; 2020 Jul; 26(3):1957-1969. PubMed ID: 31902117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoledronic acid inhibits the pentose phosphate pathway through attenuating the Ras-TAp73-G6PD axis in bladder cancer cells.
    Wang X; Wu G; Cao G; Yang L; Xu H; Huang J; Hou J
    Mol Med Rep; 2015 Sep; 12(3):4620-4625. PubMed ID: 26126921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers.
    Dai X; Xia H; Zhou S; Tang Q; Bi F
    Cancer Lett; 2019 Feb; 442():202-212. PubMed ID: 30429107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically relevant concentration of sevoflurane suppresses cervical cancer growth and migration through targeting multiple oncogenic pathways.
    Ding J; Zhang L; Zeng S; Feng T
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1179-1184. PubMed ID: 31103261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthelminthic drug niclosamide sensitizes the responsiveness of cervical cancer cells to paclitaxel via oxidative stress-mediated mTOR inhibition.
    Chen L; Wang L; Shen H; Lin H; Li D
    Biochem Biophys Res Commun; 2017 Mar; 484(2):416-421. PubMed ID: 28137584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.